Home/Filings/4/0001127602-25-013053
4//SEC Filing

Williams David Michael 4

Accession 0001127602-25-013053

CIK 0000310158other

Filed

Apr 30, 8:00 PM ET

Accepted

May 1, 6:13 PM ET

Size

8.7 KB

Accession

0001127602-25-013053

Insider Transaction Report

Form 4
Period: 2025-04-29
Williams David Michael
EVP,Chief Info&Digital Officer
Transactions
  • Award

    Restricted Stock Unit

    2025-04-29+4,1324,132 total
    From: 2026-04-29Exp: 2028-04-29Common Stock (4,132 underlying)
  • Award

    Stock Option (Right to Buy)

    2025-04-29+18,80718,807 total
    Exercise: $84.71From: 2026-04-29Exp: 2035-04-28Common Stock (18,807 underlying)
Holdings
  • Common Stock

    24,225.067
Footnotes (4)
  • [F1]Holdings include shares acquired in dividend reinvestment transactions.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
  • [F3]These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 4/29/2026, 4/29/2027 and 4/29/2028.
  • [F4]The option vests and becomes exercisable in three equal installments on 4/29/2026, 4/29/2027 and 4/29/2028.

Issuer

Merck & Co., Inc.

CIK 0000310158

Entity typeother

Related Parties

1
  • filerCIK 0001820958

Filing Metadata

Form type
4
Filed
Apr 30, 8:00 PM ET
Accepted
May 1, 6:13 PM ET
Size
8.7 KB